0001127602-17-005326.txt : 20170213 0001127602-17-005326.hdr.sgml : 20170213 20170213142816 ACCESSION NUMBER: 0001127602-17-005326 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170209 FILED AS OF DATE: 20170213 DATE AS OF CHANGE: 20170213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ratliff John D CENTRAL INDEX KEY: 0001575951 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 17598192 MAIL ADDRESS: STREET 1: C/O QUINTILES TRANSNATIONAL HOLDINGS INC STREET 2: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-02-09 0000920148 LABORATORY CORP OF AMERICA HOLDINGS LH 0001575951 Ratliff John D 531 SOUTH SPRING STREET BURLINGTON NC 27215 1 CEO, Covance Drug Development Common Stock 2017-02-09 4 M 0 6100 A 6140 D Common Stock 2017-02-09 4 F 0 2013 133.83 D 4127 D Restricted Stock Unit 2017-02-09 4 M 0 6100 0 D Common Stock 6100 17790 D Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Stock withholding to satisfy tax withholding obligations. The Restricted Stock Units vest in three equal annual installments beginning on 2/9/17. This number reflects the aggregate number of Restricted Stock Units held by the reporting person. /s/ F. Samuel Eberts III, Attorney-in-Fact for John D. Ratliff 2017-02-13